Press Releases

Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference
Arch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5™ Topical Hemostat
Arch Therapeutics to Provide Corporate Update at the 9th Annual LD Micro Invitational
Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video
Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
RSS
Show All